Senator Tom Coburn's activity on the Subcommittee on Federal Financial Management, Government Information, and International Security

Republican Office
Home | About Us | Oversight Action | Hearings | Links | Press Releases | News Stories

Latest News

News Stories




Print this page
Print this page


Federal Researcher (NIH) Faces Charges Over Consulting Fees From Pfizer


ASSOCIATED PRESS


December 5, 2006


Federal Researcher Faces Charges Over Consulting Fees From Pfizer

Federal prosecutors charged a leading government Alzheimer's researcher with engaging in a felony criminal conflict of interest by earning $285,000 in private consulting fees from a pharmaceutical giant.

In a rare criminal case against a government scientist, the National Institutes of Health's Dr. Trey Sunderland was accused of performing consulting work for Pfizer Inc. that improperly overlapped with his government duties.

The single conflict-of-interest charge, filed in U.S. District Court in Baltimore, carries a maximum of one year in prison and a $100,000 fine. Prosecutors filed the charge as a criminal information, instead of an indictment, signaling a possible plea deal.

Court papers say Dr. Sunderland failed to get proper approval from NIH for his consulting work and didn't properly report $285,000 in consulting fees and travel money from Pfizer for work that "directly related" to his federal research responsibilities.

Dr. Sunderland "did participate personally and substantially as a government employee and officer...in a particular matter in which, to the defendant's knowledge, he had a financial interest," the court papers said.

Dr. Sunderland's case was highlighted during a congressional investigation starting more than two years ago that examined the large number of NIH scientists who earned money moonlighting as outside consultants for private biotechnology and drug companies.

That investigation prompted the NIH, the government's premier health-research organization, to launch its own internal review and to institute tough new ethics rules that bar such deals. Scientists recently told NIH the new rules are so strict that many are considering leaving the agency.

Dr. Sunderland's attorney, Robert Muse, and NIH officials declined to comment on the development. He is scheduled to appear for arraignment in U.S. District Court in Baltimore on Friday.




December 2006 News




Senator Tom Coburn's activity on the Subcommittee on Federal Financial Management, Government Information, and International Security

340 Dirksen Senate Office Building     Washington, DC 20510

Phone: 202-224-2254     Fax: 202-228-3796

Email Alerts Signup!